Tirofiban vs primary intervention | No demonstrated result | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Initial TIMI 3 flow | 1.50 [0.99 2.26] | p=1.00 | 0 | 645 | 3 | On-Time (van’t Hof),TIGER-PA (Lee),Cutlip, | Final TIMI 3 flow | 0.99 [0.55 1.78] | p=1.00 | 0 | 597 | 3 | On-Time (van’t Hof),TIGER-PA (Lee),Cutlip, | urgent target vessel revascularisation | 1.30 [0.22 7.86] | p=1.00 | 0 | 650 | 3 | On-Time (van’t Hof),TIGER-PA (Lee),Cutlip, | Non fatal MI | 0.86 [0.21 3.53] | p=1.00 | 0 | 650 | 3 | On-Time (van’t Hof),TIGER-PA (Lee),Cutlip, | All cause death | 2.31 [0.66 8.03] | p=1.00 | 0 | 650 | 3 | On-Time (van’t Hof),TIGER-PA (Lee),Cutlip, | Major bleeding | 1.30 [0.58 2.91] | p=1.00 | 0 | 650 | 3 | On-Time (van’t Hof),TIGER-PA (Lee),Cutlip, | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |